Drug Patents Fare Better At PTAB Than Others, Report Says
Drug patents survive challenges at the Patent Trial and Appeal Board at a much higher rate than patents in other sectors, according to a report issued Wednesday by law firm Fitzpatrick...To view the full article, register now.
Already a subscriber? Click here to view full article